The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Harr Steve since 2015.
This trader's CIK number is 1627387.
At the time of last reporting, Harr Steve was the President & CEO of Sana Biotechnology, Inc.. (stock ticker symbol SANA).
Also see all insider trading activities at Sana Biotechnology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | JUNO | 0 | $0 | 26,250 | $918,400 | 26,250 | $228,900 |
| 2016 | JUNO | 0 | $0 | 65,000 | $2,650,380 | 0 | $0 |
| 2015 | JUNO | 0 | $0 | 35,000 | $1,632,260 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | SANA | 0 | $0 | 0 | $0 | 50,000 | $0 |
1. Juno Therapeutics, Inc. (JUNO)
2. Sana Biotechnology, Inc. (SANA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-12-21 | JUNO | Option Ex | 8,750 | 8.72 | 76,300 |
| 2017-12-21 | JUNO | Sale | 8,750 | 44.96 | 393,400 |
| 2017-07-03 | JUNO | Option Ex | 8,750 | 8.72 | 76,300 |
| 2017-07-03 | JUNO | Sale | 8,750 | 30.00 | 262,500 |
| 2017-06-27 | JUNO | Option Ex | 8,750 | 8.72 | 76,300 |
| 2017-06-27 | JUNO | Sale | 8,750 | 30.00 | 262,500 |
| 2016-06-10 | JUNO | Sale | 30,000 | 43.29 | 1,298,670 |
| 2016-03-04 | JUNO | Sale | 5,000 | 45.00 | 225,000 |
| 2016-03-01 | JUNO | Sale | 30,000 | 37.56 | 1,126,710 |
| 2015-12-10 | JUNO | Sale | 35,000 | 46.64 | 1,632,260 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-07 | SANA | Option Ex | 50,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Harr Steve (President & CEO of Sana Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.